GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharma Block Sciences (Nanjing) Inc (SZSE:300725) » Definitions » Beneish M-Score

Pharma Block Sciences (Nanjing) (SZSE:300725) Beneish M-Score : -2.58 (As of Apr. 10, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Pharma Block Sciences (Nanjing) Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Pharma Block Sciences (Nanjing)'s Beneish M-Score or its related term are showing as below:

SZSE:300725' s Beneish M-Score Range Over the Past 10 Years
Min: -3.43   Med: -1.93   Max: 1.01
Current: -2.58

During the past 11 years, the highest Beneish M-Score of Pharma Block Sciences (Nanjing) was 1.01. The lowest was -3.43. And the median was -1.93.


Pharma Block Sciences (Nanjing) Beneish M-Score Historical Data

The historical data trend for Pharma Block Sciences (Nanjing)'s Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Block Sciences (Nanjing) Beneish M-Score Chart

Pharma Block Sciences (Nanjing) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.05 -3.43 -1.92 -2.25 -2.12

Pharma Block Sciences (Nanjing) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.07 -2.12 -2.05 -2.38 -2.58

Competitive Comparison of Pharma Block Sciences (Nanjing)'s Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Block Sciences (Nanjing)'s Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Block Sciences (Nanjing)'s Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharma Block Sciences (Nanjing)'s Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Pharma Block Sciences (Nanjing)'s Beneish M-Score falls into.


;
;

Pharma Block Sciences (Nanjing) Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Pharma Block Sciences (Nanjing) for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9757+0.528 * 1.0506+0.404 * 1.0316+0.892 * 0.9178+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8508+4.679 * -0.022794-0.327 * 0.8846
=-2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ¥406 Mil.
Revenue was 383.026 + 367.406 + 377.46 + 433.742 = ¥1,562 Mil.
Gross Profit was 143.566 + 143.311 + 161.15 + 179.784 = ¥628 Mil.
Total Current Assets was ¥2,689 Mil.
Total Assets was ¥4,916 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,703 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥68 Mil.
Total Current Liabilities was ¥806 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,139 Mil.
Net Income was 33.099 + 49.206 + 49.485 + 43.315 = ¥175 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 51.802 + 81.746 + 55.33 + 98.27 = ¥287 Mil.
Total Receivables was ¥453 Mil.
Revenue was 447.404 + 460.617 + 383.441 + 409.998 = ¥1,701 Mil.
Gross Profit was 185.084 + 195.216 + 173.452 + 164.854 = ¥719 Mil.
Total Current Assets was ¥2,910 Mil.
Total Assets was ¥5,217 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,768 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥87 Mil.
Total Current Liabilities was ¥1,011 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,323 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(405.924 / 1561.634) / (453.294 / 1701.46)
=0.259935 / 0.266415
=0.9757

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(718.606 / 1701.46) / (627.811 / 1561.634)
=0.422347 / 0.402022
=1.0506

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2688.916 + 1702.749) / 4915.52) / (1 - (2910.14 + 1767.572) / 5216.646)
=0.106572 / 0.10331
=1.0316

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1561.634 / 1701.46
=0.9178

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1767.572)) / (0 / (0 + 1702.749))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(67.84 / 1561.634) / (86.879 / 1701.46)
=0.043442 / 0.051061
=0.8508

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1139.449 + 806.342) / 4915.52) / ((1323.041 + 1011.294) / 5216.646)
=0.395846 / 0.447478
=0.8846

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(175.105 - 0 - 287.148) / 4915.52
=-0.022794

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Pharma Block Sciences (Nanjing) has a M-score of -2.58 suggests that the company is unlikely to be a manipulator.


Pharma Block Sciences (Nanjing) Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Pharma Block Sciences (Nanjing)'s Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Block Sciences (Nanjing) Business Description

Traded in Other Exchanges
N/A
Address
10 Xuefu Road, Nanjing High-tech Industrial Development Zone, Jiangsu, Nanjing, 210032, CHN, 210032
Pharma Block Sciences (Nanjing) Inc is a chemistry products and services provider through the pharmaceutical research and development process. Its core business activities include pilot plant and commercial manufacturing of key intermediates and active pharmaceutical ingredient, process development, custom synthesis and building blocks.
Executives
Yang Min Min Directors, executives
Directors, executives
Chen La Mei Executives
Wu Xi Han Director
Executives
Directors, executives
Luo Fei Supervisors

Pharma Block Sciences (Nanjing) Headlines

No Headlines